0 (0%) | 04-24 19:46 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 20.33 | 1-year : | 20.84 |
Resists | First : | 17.41 | Second : | 17.85 |
Pivot price | 17.2 | |||
Supports | First : | 16.7 | Second : | 13.89 |
MAs | MA(5) : | 16.82 | MA(20) : | 17.26 |
MA(100) : | 17.25 | MA(250) : | 17.49 | |
MACD | MACD : | -0.2 | Signal : | -0.1 |
%K %D | K(14,3) : | 7 | D(3) : | 3.4 |
RSI | RSI(14): 28.2 | |||
52-week | High : | 18.38 | Low : | 16.48 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ QRMI ] has closed above bottom band by 15.9%. Bollinger Bands are 227.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 16.99 - 17.07 | 17.07 - 17.14 |
Low: | 16.56 - 16.66 | 16.66 - 16.74 |
Close: | 16.65 - 16.81 | 16.81 - 16.95 |
Mon, 15 Apr 2024
QRM Announces Appointment of Kirsten M. Early as CEO - Yahoo Finance
Wed, 06 Mar 2024
Concerns over asset quality, risk management may have prompted RBI's crackdown on NBFCs: Experts - Moneycontrol
Sat, 02 Mar 2024
Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management - Pharmaceutical Technology Magazine
Wed, 03 Jan 2024
QRM Conference 2024 | University of Gothenburg - Göteborgs universitet
Tue, 02 Jan 2024
Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan - Pharmaceutical Technology Magazine
Sat, 02 Dec 2023
The ICH Q9 Revision and a Renewed Focus on Quality Risk Management Fundamentals - Pharmaceutical Technology Magazine
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |